1. Home
  2. ALT vs SWBI Comparison

ALT vs SWBI Comparison

Compare ALT & SWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • SWBI
  • Stock Information
  • Founded
  • ALT 1997
  • SWBI 1852
  • Country
  • ALT United States
  • SWBI United States
  • Employees
  • ALT N/A
  • SWBI N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • SWBI Ordnance And Accessories
  • Sector
  • ALT Health Care
  • SWBI Industrials
  • Exchange
  • ALT Nasdaq
  • SWBI Nasdaq
  • Market Cap
  • ALT 397.4M
  • SWBI 429.0M
  • IPO Year
  • ALT N/A
  • SWBI N/A
  • Fundamental
  • Price
  • ALT $4.19
  • SWBI $8.54
  • Analyst Decision
  • ALT Strong Buy
  • SWBI Buy
  • Analyst Count
  • ALT 6
  • SWBI 2
  • Target Price
  • ALT $18.20
  • SWBI $12.00
  • AVG Volume (30 Days)
  • ALT 11.7M
  • SWBI 1.4M
  • Earning Date
  • ALT 08-07-2025
  • SWBI 09-04-2025
  • Dividend Yield
  • ALT N/A
  • SWBI 6.01%
  • EPS Growth
  • ALT N/A
  • SWBI N/A
  • EPS
  • ALT N/A
  • SWBI 0.30
  • Revenue
  • ALT $20,000.00
  • SWBI $474,661,000.00
  • Revenue This Year
  • ALT N/A
  • SWBI $8.53
  • Revenue Next Year
  • ALT $1,557,547.90
  • SWBI N/A
  • P/E Ratio
  • ALT N/A
  • SWBI $28.47
  • Revenue Growth
  • ALT N/A
  • SWBI N/A
  • 52 Week Low
  • ALT $2.90
  • SWBI $8.38
  • 52 Week High
  • ALT $11.16
  • SWBI $16.85
  • Technical
  • Relative Strength Index (RSI)
  • ALT 39.67
  • SWBI 36.14
  • Support Level
  • ALT $4.33
  • SWBI $8.53
  • Resistance Level
  • ALT $4.79
  • SWBI $8.85
  • Average True Range (ATR)
  • ALT 0.52
  • SWBI 0.23
  • MACD
  • ALT -0.16
  • SWBI -0.04
  • Stochastic Oscillator
  • ALT 26.92
  • SWBI 20.54

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About SWBI Smith & Wesson Brands Inc.

Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.

Share on Social Networks: